Zuke’s boosts pet treats portfolio
DURANGO, Colo. — Zuke’s has expanded its line of all-natural pet treats.
Supers-Zuke’s semi-moist, low gluten, antioxidant and nutrient-rich superfood treats deliver a mix of nutritious ingredients and antioxidants in three flavors, each representing different classes or superfoods: Super berries, super betas and super greens.
"Superfoods pack a lot of punch," Zuke’s founder Patrick Meiering said. "They are loaded with beneficial nutrients proven to prevent diseases and support longevity. Supers reflect the latest in animal nutrition and support our commitment to producing the most delicious and healthy treats for your pets."
Available in 6-oz. pouches, Supers-Zuke’s carries a suggested retail price of $6.99.
Senate introduces bill to restrict DXM sales to adults
WASHINGTON — Sens. Bob Casey, D.-Pa., and Lisa Murkowski, R-Alaska, on Wednesday introduced bipartisan legislation to prevent the abuse of cough syrup to get high by restricting the sale of products containing dextromethorphan to adults older than 18 years of age.
“By addressing easy access to purchasing cough syrup for teens, the main cause of the harmful trend of its abuse, my bill will help keep our children safe and lessen the strain cough syrup abuse has put on families, hospitals and law enforcement,” Casey said. “My common-sense legislation will prevent kids from purchasing a drug that has dangerous consequences when abused to get high, while also ensuring it is available to those with a legitimate need for it.”
“This legislation powerfully complements our ongoing educational initiatives to raise awareness about this troubling behavior,” CHPA president and CEO Scott Melville said. “It will give parents an additional tool to prevent abuse, while ensuring access for the millions of adults and families who responsibly use products containing DXM to relieve cough symptoms. We are extremely pleased to see such strong leadership from Sens. Casey and Murkowski and encourage Congress to pass this legislation.”
The active ingredient in many over-the-counter cough and cold medicines DXM is safe when taken as recommended, but 5% of teenagers report having intentionally taken large doses of DXM for effects that include hallucinations, confusion, blurred vision and loss of motor control. Sen. Casey’s Prevent Abuse of Cough Treatments Act will make it harder for teens to purchase the drug while still keeping cough medications accessible to those who use them for their intended purpose.
In addition to placing an age-restriction on the sale of DXM products, the PACT Act will ensure that only legitimate entities registered with the FDA or comparable state agencies can purchase raw, unfinished (bulk) dextromethorphan.
BioRx receives distribution rights to bleeding disorder drug
CINCINNATI — Days after its acquisition of Coagulife, specialty pharmacy provider BioRx has received limited distribution rights to a treatment for a bleeding disorder described as one of the rarest in the world.
The company, which specializes in treating bleeding disorders, said Wednesday that it had received the rights for Corifact (factor XIII concentrate [human]), a treatment made by CSL Behring for congenital Factor XIII deficiency. The drug received approval from the Food and Drug Administration in February 2011.
"We are very excited to begin serving the factor XIII patient population," BioRx co-founder Eric Hill said. "We are also pleased to expand our distribution partnership with CSL Behring in the bleeding disorders market."